Introduction {#s1}
============

Functional blood vessel networks are essential for vertebrate development, tissue growth and organ physiology ([@bib36]). Vessel assembly and sprouting establish the major axial vessels and a primary network, which undergoes extensive remodelling to become functional. Also in the adult, vascular networks can be reactivated, expanded to meet changing metabolic demands, or remodelled, as a consequence of injury or local occlusion ([@bib10]; [@bib36]). A large number of mouse mutants have been described as having defects in vascular remodelling. Yet, in contrast to vascular sprouting, very little is known about the intrinsic cellular and molecular mechanisms controlling vascular remodelling. One aspect of remodelling is vessel segment regression, in which existing connections are lost. Endothelial cell (EC) death drives programmed regression of the ocular hyaloid vessels ([@bib28]) and pupillary membrane ([@bib32]). Whilst a similar mechanism was thought to be driving developmental vascular remodelling, recent reports proposed that vessel segment regression in the remodelling retinal blood vessels involves dynamic rearrangement of ECs, which actively migrate from regressing vessel segments to integrate into neighbouring vessels ([@bib21]; [@bib43]). Chen et al. postulated that ECs in zebrafish brain vessels sense a threshold of low blood flow below which vessel regression is triggered irreversibly ([@bib12]). Our recent rheology modelling of the retinal plexus also predict regression of poorly perfused vessel segments ([@bib9]; [@bib21]), and demonstrated that EC axial polarization against the blood flow direction is a conserved feature in remodelling vessels ([@bib21]). Our observations lead us to propose that flow-induced EC polarization directs migration of ECs that reside in low flow or oscillatory flow segments towards juxtapose high flow segments. As a consequence, this movement of ECs between vessel segments with differential flow regimes leads to regression of low-flow branches and stabilization of the higher flow segments ([@bib21]). Blood flow is critical for vascular remodelling ([@bib22]), but the relevance and the mechanistic understanding of how physical forces and signalling pathways collectively stabilize or disrupt vessel connections remains unknown.

Here we show that ECs use non-canonical Wnt ligands in a short-range, paracrine manner to stabilize connections during vascular remodelling. We show that loss of endothelial-derived Wnt5a and Wnt11 sensitizes ECs to polarize against the blood flow direction at lower levels of wall shear stress, in vitro and in vivo, thereby leading to premature and excessive vessel regression in mouse. We postulate that the enhanced sensitivity to flow in non-canonical Wnt-deficient endothelium promotes earlier discrimination of flow asymmetries between neighbouring vessel segments in the capillary plexus, thus driving premature vessel regression and accelerated remodelling.

Results {#s2}
=======

Endothelial-derived Wnt ligands protect from premature vessel regression independent of apoptosis {#s2-1}
-------------------------------------------------------------------------------------------------

Wnt/β-catenin signalling has been shown to both promote and inhibit vessel regression ([@bib28]; [@bib35]). To gain further insight into the role of Wnt ligands in vessel regression, we conditionally inactivated Wnt-ligand secretion by recombination of the floxed *Wls/Evi/Gpr177* allele ([@bib11]) in ECs (Pdgfb-iCreERT2 or Tie2-Cre). *Wls* encodes for a transporter chaperone protein required for secretion of all Wnt ligands ([@bib4]; [@bib5]). Embryonic endothelial-specific *Wls* deletion (*Wls*^fl/fl^::Tie2-Cre) leads to mid-gestation lethality, demonstrating an important vascular function for endothelial-derived Wnt ligands ([Table 1](#tbl1){ref-type="table"}). Tamoxifen-inducible *Wls* deletion in ECs (Pdgfb-iCreERT2::*Wls*^fl/fl^, hereafter *Wls* iEC-KO) led to significantly decreased vascular density compared to littermate controls ([Figure 1a](#fig1){ref-type="fig"}). Quantification revealed increased regression profiles (quantified by the Col.IV-sleeves and Icam2-breakage profiles), while sprout frequency, proliferation, EC density and apoptosis rates were unaffected ([Figure 1b](#fig1){ref-type="fig"} and [Figure 1---figure supplement 1a,b](#fig1s1){ref-type="fig"}). Surprisingly, these results did not recapitulate recent findings by Korn et al. who reported that *Wls* iEC-KO causes increased vessel regression through increased apoptosis ([@bib25]). Our recent work established that regression in the mouse vasculature follows a sequence of events that begin with vessel stenosis, followed by cell retraction that finally leads to resolution, leaving only empty matrix behind ([@bib21]). The frequency distribution of regression profiles at these distinct stages of segment regression, i.e. stenosis, retraction or resolution, was similar in *Wls* iEC-KO and *Wls* WT mice ([Figure 1c](#fig1){ref-type="fig"}) indicating that the lack of secretion of Wnt ligands from ECs affects the frequency but not the mechanism of vessel regression. Experimental hyperoxia-induced vessel obliteration (which is driven by endothelial apoptosis ([@bib1]) caused similar central capillary network dropout in *Wls* WT and *Wls* iEC-KO, suggesting that EC Wnt-ligands are not able to significantly protect from endothelial cell apoptosis-mediated vessel regression events ([Figure 2a,b](#fig2){ref-type="fig"}). Defects in pericyte recruitment have been linked to increased vessel instability and vessel regression ([@bib6]). We analysed pericyte coverage using NG2 marker and observed no significant changes between *Wls* WT and *Wls* iEC-KO retinas ([Figure 3a,b](#fig3){ref-type="fig"}).10.7554/eLife.07727.003Table 1.Tie2-Cre *Wls*fl/fl embryos die at mid-gestation. Table showing number of embryos collected at the specified embryonic time point post-coitum (E) and at birth. Relative frequency each genotype of embryos/pups is shown as percentage.**DOI:** [http://dx.doi.org/10.7554/eLife.07727.003](10.7554/eLife.07727.003)♂ Tie2-Cre::*Wls* ^fl/wt^ X ♀ *Wls* ^fl/fl^GenotypeE12.5%E13.5%E16.5%Adults%*Wls*^fl/fl^60.2540.2970.41200.38*Wls*^fl/wt^50.2140.2940.24130.25*Wls*^fl/fl^::Cre+60.2540.294 (3 dead)0.2400.00*Wls*^fl/wt^::Cre+70.2920.1420.12200.3810.7554/eLife.07727.004Figure 1.EC-derived Wnt ligands protect against vessel regression.(**a**) Overview of retinal vascular plexus of P6 control and *Wls* iEC-KO mice, labeled for lumen (ICAM2), ECs (IB4) and ECM (Col.IV). (**b**) Quantification of vascular parameters demonstrating that increased vessel regression is a main feature of *Wls* iEC-KO in P6 retinas. IB4/Col.IV regression profiles correspond to the number Col.IV-positive segments negative for IB4 staining. ICAM2/Col.IV regression profiles correspond to number of Col.IV-positive vessel segments partially or totally negative for ICAM2 staining. p values from unpaired, two-tailed t-test. Mean +/-SEM; N = 6 mice; 3 litters. (**c**) High magnification images of the vascular plexus of control and *Wls* iEC-KO mice marked for each stage of vessel regression (stenosis, blue arrows; retraction, green arrow; resolution, red arrows). (**d**) Quantification of the each specific vessel regression stage in *Wls* iEC-KO and *Wls* WT P6 retinas (stenosis, blue bars; retraction, green bars; resolution, red bars). Two-way ANOVA with Sidak multiple comparisons test. Mean +/-SEM; N = 5 mice; 3 litters; N = 288 and N = 398 regression events for *Wls* WT and *Wls* iEC-KO mice, respectively.**DOI:** [http://dx.doi.org/10.7554/eLife.07727.004](10.7554/eLife.07727.004)10.7554/eLife.07727.005Figure 1---figure supplement 1.*Wls* iEC-KO mice show normal proliferation and apoptosis rates.(**a**) Representative confocal images of proliferation profile in *Wls* iEC-KO and *Wls* WT P6 mouse retinas labeled with ICAM2 (red), endothelial cell nuclei (Erg, green) and EdU (blue). (b) Representative segmentation of confocal images stained for active caspase-3 and blood vessels (IB4) showing distribution of endothelial cells positive for active caspase-3 (green dots) in *Wls* iEC-KO and *Wls* WT P6 mouse retinas.**DOI:** [http://dx.doi.org/10.7554/eLife.07727.005](10.7554/eLife.07727.005)10.7554/eLife.07727.006Figure 2.Oxygen-induced vessel regression is not enhanced in *Wls* iEC-KO mice.(**a**) Representative confocal images of *Wls* iEC-KO and *Wls* WT P12 mouse retinas under 70% oxygen concentration from P7 until P12, and labeled for vessel lumen (Icam2, red) and extracellular matrix (Col.IV, green). Quantification shows no significant difference in area of vessel obliteration between *Wls* iEC-KO and *Wls* WT mouse. p values from unpaired, two-tailed t-test. Mean +/-SEM; N = 6 mice; 2 litters. (**b**) Representative confocal images of *Wls* iEC-KO and *Wls* WT P16 mouse retinas under 70% oxygen concentration from P4 until P6, and labeled with vessel lumen (Icam2, red), endothelial cells (IB4, blue) and extracellular matrix (Col.IV, green). Quantification shows no significant difference in area of vessel obliteration between *Wls* iEC-KO and *Wls* WT mouse. p values from unpaired, two-tailed t-test. Mean +/-SEM; N = 6 mice; 3 litters.**DOI:** [http://dx.doi.org/10.7554/eLife.07727.006](10.7554/eLife.07727.006)10.7554/eLife.07727.007Figure 3.Normal pericytic coverage in *Wls* iEC-KO.(**a**) Overview of retinal vascular plexus of P6 control and *Wls* iEC-KO mice, labeled for endothelial cells (CD31), and pericytes (Ng2), in capillary plexus (top panels) and main vessels (bottom panels). (**b**) Quantification of pericyte coverage of retinal blood vessels, showing no significant change between control and *Wls* iEC-KO in P6 retinas. p values from unpaired, two-tailed t-test. Mean +/-SEM; N = 4 mice; 2 litters.**DOI:** [http://dx.doi.org/10.7554/eLife.07727.007](10.7554/eLife.07727.007)

Endothelial non-canonical Wnt ligands prevent premature vessel regression {#s2-2}
-------------------------------------------------------------------------

RT-PCR profiling on RNA extracts from isolated P7 retinal ECs ([Figure 4a](#fig4){ref-type="fig"}) identified expression of Wnt ligands associated with canonical (*Wnt3, Wnt3a, Wnt6, Wnt7b, Wnt9a* and *Wnt10a*) and non-canonical (*Wnt5a* and *Wnt11*) Wnt signalling. Expression of the canonical Wnt/β-catenin-dependent targets *Axin2, CyclinD1* and *Lef1 *([@bib14]) were unaffected in *Wls* iEC-KO ([Figure 4b,c](#fig4){ref-type="fig"}), and nuclear Lef1 levels were even slightly increased ([Figure 4d](#fig4){ref-type="fig"}). Intercrossing the canonical Wnt signalling reporter mouse BAT-gal ([@bib31]) also revealed no differences in X-gal positive ECs ([Figure 4e](#fig4){ref-type="fig"}). Also expression of endothelial Dll4/Notch signalling components, potentially influenced by canonical Wnt signalling ([@bib16]), was unaffected ([Figure 4b,c](#fig4){ref-type="fig"}). Together, these findings identify that canonical Wnt signalling is intact in *Wls* iEC-KO, and suggest that the observed increase in regression was possibly due to loss of endothelial non-canonical Wnt signalling.10.7554/eLife.07727.008Figure 4.*Wls* iEC-KO show no significant defects in canonical Wnt signalling.(**a**) RT-PCR for all known mouse Wnt ligands using mRNA extracts from isolated retinal endothelial cells of P7 wild-type retinas (red text represents positive bands). (**b**) Semi-quantitative real-time analysis of mRNA expression levels of different genes in P6 *Wls* iEC-KO retinas normalized to *Wls* WT retinas from whole retina extracts. p values from unpaired, two-tailed t-test. Mean +/- SD; N = 4 mice; 2 litters. (**c**) Semi-quantitative real-time analysis of mRNA expression levels of different genes in P6 *Wls* iEC-KO normalized to *Wls* WT from isolated lung endothelial cells. p values from unpaired, two-tailed t-test. Mean +/-SEM; N = 3 mice; 2 litters. (**d**) Lef1 immunostaining and quantification of fluorescence intensity (graph right) in endothelial cells (IB4) from *Wls* iEC-KO and *Wls* WT retinas. p values from unpaired, two-tailed t-test. Mean +/- SEM; N = 234 *Wls* WT cells and N = 128 *Wls* iEC-KO cells; 4 mice. (**e**) X-gal staining, indicative of canonical Wnt signalling activation, in *Wls* iEC-KO; BAT-gal and *Wls* WT; BAT-gal retinas. No correlation was found with X-gal positive cells and regression profiles (visualized by ECM (Col.IV) and lumen (Icam2) stainings).**DOI:** [http://dx.doi.org/10.7554/eLife.07727.008](10.7554/eLife.07727.008)

Indeed, endothelial-specific *Wnt5a* inactivation (*Wnt5a*^fl/fl^::Pdgfb-iCreERT2, hereafter *Wnt5a* iEC-KO) led to increased vessel regression, decreased vascular density and a mild decrease in radial vascular expansion ([Figure 5a,b](#fig5){ref-type="fig"}). Constitutive *Wnt11* KO mice showed a milder phenotype with a slight decrease in radial expansion, but no significant differences in vascular density ([Figure 5a,b](#fig5){ref-type="fig"}). However, compound *Wnt5a* endothelial-specific KO and *Wnt11* KO mice, named *Wnt5a* iEC-KO; *Wnt11* KO hereafter, largely phenocopied the vascular defects of *Wls* iEC-KO mice ([Figure 6a,b](#fig6){ref-type="fig"}). As in *Wls* iEC-KO mice, ECs numbers and apoptosis rate were unaffected in *Wnt5a* iEC-KO; *Wnt11* KO ([Figure 6a,b](#fig6){ref-type="fig"}). Also the tracheal vasculature, undergoing post-natal remodelling ([@bib3]), showed a significant decrease in vascular density in *Wnt5a* iEC-KO; *Wnt11* KO, and an associated increase in vessel regression events ([Figure 6c,d](#fig6){ref-type="fig"}). We conclude that endothelial-derived non-canonical Wnt ligands prevent excessive and premature vessel disconnection.10.7554/eLife.07727.009Figure 5.Characterization of vascular parameters in *Wnt5a* iEC-KO and *Wnt11* KO retinas.(**a**) Overview of retinal vascular plexus of P6 *Wnt5a* iEC-KO, *Wnt11* KO, and corresponding control mice, labeled with ECM (Col.IV, grey). (**b**) Quantification of different vascular parameters in P6 retinas on the different mouse strains. p values from unpaired, two-tailed t-test. Mean +/-SEM; N = 5 mice; 3 litters.**DOI:** [http://dx.doi.org/10.7554/eLife.07727.009](10.7554/eLife.07727.009)10.7554/eLife.07727.010Figure 6.Non-canonical Wnt signalling regulates vessel regression.(**a**) Overview of retinal vascular plexus of control and compound *Wnt5a* iEC-KO; *Wnt11* KO mice, labelled with lumen (Icam2) and ECM (Col.IV) markers. (**b**) Quantification of different vascular parameters showing increased vessel regression in *Wnt5a* iEC-KO; *Wnt11* KO retinas. p values from unpaired, two-tailed t-test. Mean +/-SEM; N = 7 mice; 3 litters. (**c**) Overview of trachea vascular plexus of P6 *Wnt5a* iEC-KO; *Wnt11* KO and control mice labelled for CD31 (green). (**d**) Quantification of vessel density and regression profiles in the trachea of *Wnt5a* iEC-KO; *Wnt 11* KO and WT P6 mice. p values from unpaired, two-tailed t-test. Mean +/-SEM; N = 4 mice; 2 litters.**DOI:** [http://dx.doi.org/10.7554/eLife.07727.010](10.7554/eLife.07727.010)

Non-canonical Wnt signalling modulates endothelial response to flow-dependent wall shear stress {#s2-3}
-----------------------------------------------------------------------------------------------

We recently showed that EC nucleus-to-Golgi axial polarity predicts migration patterns at sites of vessel regression in vivo, and that differential flow/shear patterns in juxtaposed vessels drive asymmetries in cellular movements, thus promoting stabilization of high-flow and regression of low-flow vessel segments ([@bib21]). Further, we have developed a computational approach to simulate blood flow in retinal networks and calculate wall shear stress and flow patterns ([@bib9]). Given the known involvement of non-canonical Wnt signalling in Planar Cell Polarity (PCP) and cell polarization ([@bib17]; [@bib39]) we hypothesized that *Wls* iEC-KO could have defects in cell polarization. We therefore analysed if non-canonical Wnt signalling could influence coordinated polarization of ECs in vivo and in response to flow. We stained *Wls* iEC-KO and control mice for Golgi, lumen, and EC nuclei and extracted maps of axial polarity for entire retinal vascular networks ([@bib21]), in a novel analysis methodology that we call hereafter Polarity Network (PolNet) analysis ([Figure 7a](#fig7){ref-type="fig"} and [Figure 7---figure supplement 1](#fig7s1){ref-type="fig"}). To measure efficiency of endothelial polarization in response to flow, we calculated the angle between the axial polarity vectors and the predicted flow vectors ([Figure 7b](#fig7){ref-type="fig"}). Similar to controls, *Wls* iEC-KO EC cells significantly polarize against blood flow direction across all assessed regions of the network ([Figure 7c](#fig7){ref-type="fig"}). Surprisingly, *Wls* iEC-KO ECs in capillaries, the regions of active remodelling, showed significantly better polarization against the blood flow compared to control cells ([Figure 7d](#fig7){ref-type="fig"}). When plotting the percentage of cells polarized within 45 degrees of anti-parallel orientation to flow against the computationally predicted wall shear stress, WT and *Wls* iEC-KO cells segregated such that Wnt-deficient cells reached 60 percent of cells polarizing already at less than 4 Pa whereas WT cells needed more than 7 Pa of shear to reach 60 percent ([Figure 7e](#fig7){ref-type="fig"}). These data suggest that loss of endothelial-derived non-canonical Wnt ligands substantially increases the sensitivity of cells to shear.10.7554/eLife.07727.011Figure 7.Endothelial-derived Wnt ligands modulate endothelial polarization in response to wall shear stress.(**a**) Example of axial polarity of an *Wls* iEC-KO P6 retina, labeled for EC nuclei (Erg), lumen (Icam2) and Golgi (Golph4) (i), corresponding image segmentation of the vascular plexus with axial polarity vectors in red (ii), flow pattern simulation of the selected area (iii), and correlation between axial polarity and blood flow direction at the endothelial nuclear position (iv). (**b**) Representation of the principle of angle calculation between axial and flow polarities of endothelial nuclei in (a), highlighting the lumen of blood vessels (grey), and the axial polarity of all ECs (red arrows). (**c**) Analysis of the endothelial axial polarity angle in the main vessels, relative to predicted blood flow direction by the rheology in silico model in *Wls* WT and *Wls* iEC-KO mice (n = 3 retinas). (**d**) Quantitative analysis of the percentage of ECs polarized at 180°(± 45°) degrees compared to the flow direction in the different vascular beds of *Wls* WT and *Wls* iEC-KO mice (n = 3 retinas). (**e**) Correlative analysis of wall shear stress and EC polarization in the capillary vascular bed of *Wls* WT and *Wls* iEC-KO mice. (**f**) Representative graph showing the distribution of scalar products in function to wall shear stress levels for ECs from *Wls* iEC-KO capillaries. Scalar product corresponds to the product between length of the axial polarity vector and the cosine of the angle between the axial polarity vector and the flow direction vector. (**g**) Linear regression analysis of positive (polarized with flow) and negative (polarized against the flow) scalar product points for each endothelial cell nucleus. Gradient, R-value and number of cells analyzed for each vascular bed and genotype are shown. N = 3 retinas.**DOI:** [http://dx.doi.org/10.7554/eLife.07727.011](10.7554/eLife.07727.011)10.7554/eLife.07727.012Figure 7---figure supplement 1.Endothelial polarization patterns in *Wls* iEC-KO.(**a**) Image segmentation of the vascular plexus of an *Wls* iEC-KO mouse retina, highlighting the lumen of blood vessels (grey) and the nucleus-to-golgi (axial) polarity of all endothelial cells (red arrows).**DOI:** [http://dx.doi.org/10.7554/eLife.07727.012](10.7554/eLife.07727.012)

To directly investigate whether non-canonical Wnt ligands regulate the sensitivity of ECs to polarize against the flow, we used a microfluidic device to test endothelial polarization in cultured monolayers exposed to laminar flow induced shear stress ([@bib45]). Intriguingly, siRNA-mediate knockdown of Wnt5a and Wnt11 in HUVECs led to a significant increase in polarization against the blood flow in this reductionist in vitro system suggesting that loss of endothelial Wnts directly affects aspects of endothelial cell biology involved in shear sensing and/or transduction ([Figure 8a,b](#fig8){ref-type="fig"}).10.7554/eLife.07727.013Figure 8.Non-canonical Wnt signalling modulates flow-induced polarity but not flow-induced transcriptional gene expression response.(**a**) Rose-plot representation of axial polarity of ECs treated with Control or *Wnt5a* and *Wnt11* specific siRNAs in static conditions or in response to 2 Pa flow in a microfluidic device (n = 3 independent experiments). Line running from the center represents the Mean of the dataset. Arcs extending to either side represent the 95% confidence limits of the mean (red means not significantly polarised; black means significantly polarised). (**b**) Representative images of endothelial cell polarity in flow chamber stained for nuclei (Dapi, Blue) and Golgi apparatus (GM130, green), and corresponding axial polarity vectors (black arrows). (**c**) Quantitative analysis of EC polarization related to the flow direction in the microfluidic device. p values from non-parametric two-tailed Kuiper's test. (**d**) Semi-quantitative real-time analysis of mRNA expression levels of different genes in Control or *Wnt5a* and *Wnt11* specific siRNAs in static or stimulated with 2 Pa conditions in a microfluidic device. p values from one-way ANOVA with multiple comparisons. Mean +/-SD; N = 3 independent experiments.**DOI:** [http://dx.doi.org/10.7554/eLife.07727.013](10.7554/eLife.07727.013)

In addition to polarizing cells, flow triggers a well-documented transcriptional response of a number of genes including *Klf2, Klf4*, and *Ptgs2 *([@bib22]). Moreover, VE-cadherin, VEGFR2 and PECAM1 have been described to act in a complex sensing and relaying flow-mediated shear forces ([@bib42]). To understand whether Wnt affected a more general sensitivity to flow, we therefore studied transcriptional levels following Wnt5a and Wnt11 knockdown. Interestingly, HUVECs depleted of Wnt5a and Wnt11 reacted transcriptionally to flow in the same order of magnitude as control cells for all genes analysed ([Figure 8c](#fig8){ref-type="fig"}). These data indicate that the mechanism of sensing and transducing flow signals into axial polarization differs from the mechanism triggering the transcriptional responses, such that endothelial Wnt-ligands only affect the former but not the latter.

To understand how increasing shear influences the remodelling process in dependence on Wnt signalling, we injected systemically angiotensin II to increase blood flow and therefore augment wall shear stress levels. Quantification of regression profiles showed an increase in the number of regression profiles in retinas from both *Wls* WT and *Wls* iEC-KO mice ([Figure 9a,b](#fig9){ref-type="fig"}), with angiotensin II-treated control mice having similar numbers of regression profiles as non-treated *Wls* iEC-KO mice, with a corresponding decrease in vessel density ([Figure 9b](#fig9){ref-type="fig"}). We then used our previously described PolNet analysis to evaluate polarisation patterns of ECs after systemic angiotensin II treatment ([Figure 9c](#fig9){ref-type="fig"}). Notably, we observed a significant increase in the polarisation of endothelial cells against the blood flow direction in the capillary network ([Figure 9d](#fig9){ref-type="fig"}). Thus, increasing shear forces, or the sensitivity of the endothelium to shear-induced polarization appears to have the same effect on remodelling, and can act synergistically.10.7554/eLife.07727.014Figure 9.Systemic Angiotensin-II treatment accelerates vessel regression independent of Wnt signalling.(**a**) Overview of retinal vascular plexus of P7 control and *Wls* iEC-KO mice treated with angiotensin II, labelled for lumen (Icam2) and ECM (Col.IV). (**b**) Quantification of radial expansion, vessel density and regression profiles in angiotensin II-treated and PBS-treated control retinas. p values from one-way ANOVA with Holm-Sidak's multiple comparison test. Mean +/-SEM; N = 4 mice; 3 litters. (**c**) Analysis of the endothelial axial polarity angle in the main vessels, correlated to predicted blood flow direction by the rheology in silico model in *Wls* WT and *Wls* iEC-KO mice treated with angiotensin II. (**d**) Quantitative analysis of the percentage of ECs polarized at 180°(± 45°) degrees compared to the flow direction in the different vascular beds of *Wls* WT and *Wls* iEC-KO mice with and without angiotensin II treatment (n = 3 retinas).**DOI:** [http://dx.doi.org/10.7554/eLife.07727.014](10.7554/eLife.07727.014)

Finally, we asked whether increasing non-canonical Wnt signalling can lower the sensitivity to shear, and thus prevent vessel regression. Surprisingly, inducible endothelial overexpression of *Wnt5a* (hereafter *Wnt5a* OE) had no effect on vessel regression and vascular density under normal conditions ([Figure 10a--c](#fig10){ref-type="fig"}), illustrating that increased and sustained *Wnt5a* levels are not sufficient to prevent physiological vessel remodelling. Moreover, *Wnt5a* OE failed to prevent the angiotensin-II-mediated increase in vessel regression and decrease in vessel density ([Figure 10a--c](#fig10){ref-type="fig"}). Thus, our results show that non-canonical Wnt signalling is not used as a mechanism to drive flow-dependent vessel regression, but its absence sensitizes ECs to flow-induced regression.10.7554/eLife.07727.015Figure 10.Overexpression of *Wnt5a* in endothelial cells does not inhibit vessel regression.(**a**) Overview of retinal vascular plexus of P6 endothelial-specific *Wnt5a* GOF and corresponding control mice, labeled for ECM (Col.IV, green), blood vessels (IB4, blue) and vascular lumen (Icam2, red). (**b**) Higher magnification of retinal vascular plexus of P6 endothelial-specific *Wnt5a* GOF and corresponding control mice, labeled for ECM (Col.IV, green), blood vessels (IB4, blue) and vascular lumen (Icam2, red). (**c**) Quantification of vascular parameters showing no significant differences between *Wnt5a* GOF and corresponding control retinas, with indicated treatments. p values from one-way ANOVA with Holm-Sidak's multiple comparison test. Mean +/-SEM; N = 4 mice; 2 litters.**DOI:** [http://dx.doi.org/10.7554/eLife.07727.015](10.7554/eLife.07727.015)

Discussion {#s3}
==========

Endothelial cell-autonomous control of developmental vessel regression onset {#s3-1}
----------------------------------------------------------------------------

Our present results show that ECs have intrinsic molecular mechanisms that regulate the flow-dependent shear stress response in vivo, which are important to control cell polarity and vessel regression in vascular remodelling. We show that ECs secrete non-canonical Wnt ligands (Wnt5a and Wnt11) that decrease the capacity of ECs to orientate against the direction of blood flow specifically in vascular capillaries.

Interestingly, we found that non-canonical Wnt signalling acts as a permissive rather than an instructive cue. Deleting *Wnt5a* and *Wnt11* did not change the overall pattern of the vascular network, and overexpressing *Wnt5a* in ECs of mouse retinas did not affect normal levels of vessel regression or vascular morphology. Thus, our results suggest that flow-induced vessel regression governs the overall mechanism that selects which vessel segments are redundant and non-functional to undergo regression, and that a basal level of non-canonical Wnt signalling is present to decrease the sensitivity of ECs to the flow-dependent remodelling program ([Figure 11](#fig11){ref-type="fig"}).10.7554/eLife.07727.016Figure 11.Working model for non-canonical Wnt signalling regulation of flow-induced remodeling.Initiation of the vascular remodeling program is dependent on the level of wall shear stress (threshold) to which ECs robustly polarize against the flow direction. Below the threshold, ECs movements in the immature plexus are balanced by countermovements of adjacent ECs maintaining vessel connections, in a state of dynamic stability. When exposed to shear stress levels above the response threshold, ECs react by polarizing and migrating against the flow direction, triggering vessel regression and vessel remodeling. Signaling pathways influencing the threshold for flow-dependent EC polarization can delay remodeling (raising the threshold) or induce premature remodeling (lowering the threshold), as in the case of deficient non-canonical Wnt signaling.**DOI:** [http://dx.doi.org/10.7554/eLife.07727.016](10.7554/eLife.07727.016)

Our results go against a recent proposal by Korn et al., who concluded that non-canonical Wnt signalling was involved in the regulation of ECs survival and apoptosis ([@bib25]). We find no evidence for decreased EC proliferation, or increased EC apoptosis upon loss of *Wls* or *Wnt5a/Wnt11*, in both *in vivo* and *in vitro* experiments. Korn et al. used TNP-470 to inhibit non-canonical Wnt signalling, a compound which inhibits the broad-spectrum enzyme methionine aminopeptidase-2, and that has been suggested to also interfere with VEGF signalling, a major regulator of cell proliferation and survival ([@bib19]; [@bib40]). Our study instead used selective genetic loss-of-function, potentially explaining some of the differences. Our results point to a distinct effect of non-canonical Wnt signalling on EC polarity in response to flow. In the light of recent reports showing that developmental vessel regression is driven by cell migration/rearrangements under the influence of flow ([@bib12]; [@bib21]; [@bib24]; [@bib27]; [@bib26]; [@bib37]; [@bib43]), our observed effects on EC polarity are likely the main driving force for enhanced vessel regression in our mouse mutants.

Non-canonical Wnt signalling controls vessel regression by modulating the threshold for flow-induced EC polarization {#s3-2}
--------------------------------------------------------------------------------------------------------------------

The levels of vessel regression in both wild-type and *Wls* iEC-KO mice could be manipulated by administration of angiotensin II, a potent vasoconstrictor. Interestingly, angiotensin II-treated wild-type animals showed similar levels of vessel regression as untreated *Wls* iEC-KO mice, and the same drug could further raise regression levels in *Wls* iEC-KO mice. This data further suggests that non-canonical Wnt signalling effects in vessel regression are indeed blood flow-dependent. But most importantly, it suggests the existence of a shear stress threshold for the onset of vessel regression. Our quantitative analysis combining EC axial polarity patterns and *in silico* flow simulations shows that with increasing shear more cells are polarized better, further advocating for the presence of a shear threshold. We propose that non-canonical Wnt signalling regulates this threshold. How mechanistically Wnt5a and Wnt11 controls this threshold remains unresolved. Interestingly, Martin Schwartz group showed that HUVECs have a defined threshold to polarize parallel to flow, and that VEGFR3 acts as a modulator of blood flow shear response by regulating the flow sensor VEGFR2/VEcadherin/Pecam1 ([@bib2]). Non-canonical Wnt signalling could interact with this pathway and thus impact on the flow shear stress sensor. However, our analysis demonstrated that Wnt5a and Wnt11-depleted HUVECs activate expression of key components in flow sensing (*Klf2, Klf4, Ptgs2*) in the same order of magnitude as control cells, suggesting that non-canonical Wnt signalling modulates the physical reorganization of cell polarity rather than flow sensing itself.

Implications for vascular remodelling {#s3-3}
-------------------------------------

The profound motility and rearrangement of ECs in the immature vascular plexus ([@bib12]; [@bib21]; [@bib23]; [@bib37]) implies that ECs need to coordinate their cellular movements in order to maintain vessel integrity and vessel connections. We propose that the primitive network before flow onset, or at a subthreshold level of flow, is in a state of dynamic stability where the movement of cells is less directional, but balanced by countermovements of adjacent cells such that the network remains open and lumenised. In this context, non-canonical Wnt signalling is likely to facilitate coordinated EC behaviour balancing cell movements in low-flow segments. Flow-induced polarity will supersede this mechanism driving ECs to polarize against the flow direction. It is tempting to speculate that flow-independent cell rearrangements and flow-induced cell movements stand in some form of competition to each other. Whereas the balancing rearrangements act to maintain vessels open even under low-flow conditions, flow-induced polarization introduces a bias in the system that leads to stenosis and regression of low-flow vessel segments. Thus, one could assume that forces or signals that drive cells to maintain the vessel open need to be overcome by the flow induced polarization event. What drives the rearrangements of cells in the primitive plexus and how flow in one segment initiates regression in another is poorly understood.

Recent results show that VE-cadherin organizes the junctional and cortical actin cytoskeleton, ([@bib38]), and that differential VE-cadherin dynamics drive cell rearrangements ([@bib7]). Cells with higher VEGF signalling and lower Notch activity show increased mobility by displaying a larger mobile fraction of VE-cadherin at their junctions ([@bib7]). Whether this also holds true for events during regression is unclear. However, given that Notch is also active in remodelling ([@bib18]; [@bib29]), VE-cadherin is a component of EC-to-EC and fluid shear stress force sensing ([@bib15]), and that VE-cadherin is implicated in coordinating endothelial polarity in collective migration ([@bib44]), it is tempting to speculate that rearrangements in the primitive plexus involve Notch signalling as a driver of differences in cell motility, and that non-canonical Wnt works as a signalling pathway to balance net movements through coordination of cell cohesion, enabling symmetry of movements. Flow will break this symmetry in the primitive network as it provides an extrinsic directional signal that will polarize EC movements preferentially out of the low-flow segments and into the high-flow segments.

Materials and methods {#s4}
=====================

Mice and treatments {#s4-1}
-------------------

The following mouse strains were used: *Wls*^fl^ ([@bib11]); Pdgfb-iCreERT2 ([@bib13]); *Wnt5a*^fl^ ([@bib33]); *Wnt11*^-^ ([@bib30]); Bat-Gal ([@bib31]); R26mTmG ([@bib34]); and *Wnt5a* GOF (unpublished, provided by T. Yamaguchi, details will be published in a different report). Mice were maintained at the London Research Institute under standard husbandry conditions. Tamoxifen (Sigma, Germany) was injected intraperitoneally (IP) (20 μl/g of 1 mg/mL solution) at postnatal day 2 (P2) before eyes were collected at P5 onwards. In mosaic recombination experiments tamoxifen was injected (20 μl/g of 0.04 mg/mL solution) at P3 before eyes were collected at P6, as described previously ([@bib20]).

For EC proliferation assessment in the retina, mouse pups were injected IP 4 hr before collection of eyes with 20 ul/g of EdU solution (0.5 mg/mL; Thermo Fischer Scientific, Waltham, Massachusetts, USA, C10340). Oxygen-dependent vessel obliteration was achieved using two different regimes of hyperoxia. At P4 (regime 1) or P7 (regime 2) pups were place in 70% oxygen chamber until P6 (regime 1) or P12 (regime 2). Animals were sacrificed immediately after hyperoxia treatment and processed for retinal vasculature analysis. Angiotensin II (10 mg/mL in PBS; Sigma) was injected IP 10 μL/g daily at P4, P5 and P6 and pups were culled at P7. Control mice were injected using PBS alone. Animal procedures were performed in accordance with the Home Office Animal Act 1986 under the authority of project license PPL 80/2391. The investigators were not blinded to allocation during experiments and outcome assessment and the experiments were not randomized.

Cell culture and microfluidic chamber experiments {#s4-2}
-------------------------------------------------

HUVECs (PromoCell, Germany) were routinely cultured in EGM2-Bulletkit (Lonza, Switzerland) and mycoplasma tested. For siRNA experiments, HUVECs were transfected with ON-TARGET smart pool control untargeting (D-001210-02-20) and siRNAs against human *Wnt5a* (L-003939-00-0005), *Wnt11* (L-009474-00-0005), were purchased from Dharmacon (Lafayette, Colorado, USA). HUVECs were transfected with 25 nM siRNA using the Dharmafect 1 transfection reagent following Dharmacon protocols. Twenty-four hours post transfection HUVECs were plated at confluence in IBIDI slides (height 0.6 mm, IBIDI, Germany). Sixteen hours later, unidirectional laminar shear stress (SS) was applied using peristaltic pumps (Gilson, France) connected to a glass reservoir (ELLIPSE, France) and to the IBIDI slide. Local shear stress was calculated using Poiseuille's law and averaged 2 Pa. Cells were exposed to shear stress for 4 hr using EGM2 media (Lonza) and then fixed using 100% cold-methanol for 10 min and washed three times in PBS. Cells were then stained for Golgi (GM130, 1/500, BDBiosciences, Franklin Lakes, NJ) and nucleus (DAPI, 1/10000, Sigma). Polarity of cell was evaluated looking at the angle formed by the nucleus-Golgi main axe compared to flow direction. Orientation of the cell was evaluated by looking at the angle of major axe of the nucleus compared to flow direction. For each experiment, five fields containing more than 90 cells have been analysed.

Immunofluorescence {#s4-3}
------------------

Eyes were collected from P5 onwards and fixed with 2% PFA in PBS for 5 hr at 4°C, thereafter retinas were dissected in PBS. Blocking/permeabilisation was performed using Claudio's Blocking Buffer (CBB) ([@bib20]), consisting of 1% FBS (Thermo Fisher Scientific), 3% BSA (Sigma), 0.5% triton X100 (Sigma), 0.01% Na deoxycholate (Sigma), 0,02% Na Azide (Sigma) in PBS pH = 7.4 for 2--4 hr at 4°C on a rocking platform. Primary and secondary antibodies were incubated at the desired concentration in 1:1 CBB:PBS at 4°C overnight in a rocking platform. A list of primary and corresponding secondary antibodies can be found in [Supplementary file 1](#SD1-data){ref-type="supplementary-material"}. Dapi (Sigma) was used for nuclei labeling. Retinas were mounted on slides using Vectashield mounting medium (Vector Labs, H-1000, Burlingame, CA). For imaging we used a Carl Zeiss LSM780 scanning confocal microscope (Zeiss, Germany).

FACS of endothelial cells from neonatal mouse retinas {#s4-4}
-----------------------------------------------------

Retinas from neonatal P7 mice were dissected in cold PBS and rinsed in PBS. Retinal cells were dissociated with 1 mg/ml Collagenase A (Roche, Germany, 10103578001), 3 U/ml DnaseI (Roche) in DMEM (Thermo Fisher Scientific) at 37°C for 30 min and cell suspension was passed through cell strainer. After several washes in PBS, cell suspension was incubated with PE rat anti-mouse CD31 (BD Biosciences, 553373) and APC rat Anti-Mouse CD45 (BD Biosciences,561018) antibodies on ice for 15 min. Cells were then washed and applied to FACS. RNA from CD31+CD45- cells was extracted using QIAGEN microRNA kit (Netherlands). PCR for the different Wnt ligands were performed with standard PCR protocols using primers listed in [Supplementary file 2](#SD2-data){ref-type="supplementary-material"}.

Dynabead-mediated isolation of lung endothelial cells from neonatal mice {#s4-5}
------------------------------------------------------------------------

To isolate murine endothelial cells we adapted the protocol described in Sun et al. ([@bib41]). Briefly, lungs of P6 mouse pups were removed, minced using forceps, and digested with 1% Collagenase-A supplemented with DNAseI (3 U/mL) in HBSS with calcium/magnesium for 60 min at 37°C. Digested tissues were passed through a 14-gauge needle and then filtrated through a 40-µm cell strainer. The cell suspension was incubated for 45 min at 4°C with 50 µl of magnetic Dynabeads (Thermo Fisher Scientific) that had been conjugated overnight with anti--mouse CD31 antibody in PBS/EDTA 2 mM and 2%BSA in a rocking platform. Cells with beads attached were collected using an MPC magnet (Thermo Fisher Scientific) and washed 6 to 8 times with PBS/EDTA 2 mM and 2%BSA. Endothelial cell fraction and non-endothelial fraction was then centrifuged and ressuspended in lysis buffer from RNeasy MiniKit (Qiagen) and stored at -80°C prior RNA isolation using RNeasy MicroKit (Qiagen).

Gene expression assays {#s4-6}
----------------------

For mouse retina gene expression profiling, eyes were collected and retinas dissected in RNAlater (Qiagen). Retinal RNA extraction was done using RNeasy MicroKit (Qiagen). For HUVEC gene expression profiling, treated or control cells were collected directly in RLT lysis buffer from the RNeasy MicroKit (Qiagen) and further processed for RNA isolation. Reverse transcription of mRNA was performed using First-Strand cDNA Synthesis Kit (Roche) using the manufacturer recommended protocol. Semi-quantitative real time-PCR was performed using a 7900HT Fast Real-Time PCR System and Taqman gene expression probes (Applied Biosystems, Thermo Fisher Scientific). A list of primers used for gene expression profiles can be found in [Supplementary file 3](#SD3-data){ref-type="supplementary-material"}.

Whole-mount X-Gal staining {#s4-7}
--------------------------

Mouse pups eyes at the desired stage were collected in 1% PFA and kept at 4°C for 4 hr. Retinas were dissected and washed twice in PBS. X-gal staining was developed in 2 mM MgCl2 (Sigma), 0.01% Na deoxycholate (Sigma) and 0.02% Nonidet P-40 (Sigma), 5 mM K3Fe(CN)6 (Sigma), 5 mM K4Fe(CN)6 (Sigma), and 0.5 mg/mL X-gal (Promega) in PBS pH = 7.4 at 35°C in a rocking platform. After X-gal staining, retinas were processed as for further antibody stainings. X-gal signal was obtained by exciting X-gal precipitate with the helium--neon laser 633 nm wavelength.

PolNet analysis {#s4-8}
---------------

Given the complexity and technical aspects of the PolNet Analysis the full details related to the methodology will be published in a separate manuscript. We present here a brief description of our methodology.

First, the plexus was manually segmented using Adobe Photoshop (San Jose, CA), producing a binary mask which was subsequently skeletonized using a Voronoi diagram based method (<http://uk.mathworks.com/matlabcentral/fileexchange/27543-skeletonization-using-voronoi>). The local vessel diameters were calculated using maximum inscribed circles at multiple positions along each vessel segment and this information was used to construct a 3D model of the plexus ([@bib9]), code available at <https://github.com/UCL/BernabeuInterface2014>). The surface defined by this model was used as the input to a Lattice Boltzmann Computational Fluid Dynamics solver, HemeLB (<https://github.com/UCL/hemelb>), run on a High Performance Computing cluster. The raw fluorescence images were processed in MATLAB using the built-in \'Ginput\' function to add points corresponding to the nucleus and Golgi of each cell and recording their locations. These positions defined a vector with magnitude and angle describing the spatial relationship between the points. Pairs of points were recorded for each cell, one at the center of the nucleus and one at the center of the Golgi, defining a vector with a magnitude and angle describing the spatial relationship between the points. The WSS values from the flow simulation were recorded at the positions of the cell nuclei, with the WSS at each point described by a vector giving the magnitude and angle of the applied shear stress. Each plexus was subdivided into artery, vein, capillary and sprouting front regions and each cell assigned to one of these vascular beds. The angular distributions were compared using the Kuiper test (the circular statistics equivalent of the Kolmogorov Smirnov test) with each comparison yielding a p-value indicating the likelihood that the two samples are drawn from the same underlying angular distribution. The calculation was performed using the Circular Statistics Toolbox from MATLAB's FileExchange ([@bib8]). In addition we binned the angular data according to WSS magnitude to plot the proportion of cells within 45° of being anti-aligned with the flow as a function of WSS. We calculated the scalar product of the two vectors, given by magnitude(cell polarity)\*magnitude(WSS)\*cos(theta) which combines information about the length and relative angles of the vectors. By plotting the scalar product versus WSS, we were able to extract a gradient corresponding to magnitude(cell)\*cos(theta), i.e. the projection of the cell polarity vector onto the axis defined by the WSS vector. A larger negative gradient corresponds to a larger polarization effect for a given WSS.

Quantification measurements and statistical analysis {#s4-9}
----------------------------------------------------

Complete high-resolution three-dimensional (3D) rendering of whole mount retinas were acquired using a LSM780 laser-scanning microscope (Zeiss). Tiled scans of whole retinas were analyzed with Imaris (Bitplane, [Andor Technology](https://www.google.pt/search?num=30&q=Andor+Technology&stick=H4sIAAAAAAAAAOPgE-LSz9U3ME1LtkxJUwKzjQpNky3LtAwyyq30k_NzclKTSzLz8_Tzi9IT8zKrEkGcYquCxKLUvBIFZEEAN8mtl0wAAAA&sa=X&ved=0ahUKEwisufKluLHLAhWDaRQKHWSzAUQQmxMIggIoATAj), United Kingdom) or ImageJ. Radial expansion corresponds to the mean distance from the optic nerve to the edge of the sprouting blood vessels (4 measurements per retina were done and averaged). Vessel density corresponds to the vascular area (measured by thresholding isolectin B4 signal in ImageJ) divided by the total area of vascularized tissue (3--5 20x objective images of regions between artery and vein were used per retina). Number of branching points was measured by manually quantifying all branching points in 3--5 20x objective images, of regions between artery and vein per retina, and dividing by the total area of vascularized tissue. Regression profiles were manually measured in 3--5 20x objective images and divided by the total area of vascularized tissue. IB4/Col.IV regression profiles correspond to the number of empty basement membrane collagen sleeves, i.e. Col.IV-positive segments negative for IB4 staining. ICAM2/Col.IV regression profiles correspond to number of Col.IV-positive vessel segments and segments negative for ICAM2 staining or presenting a breakage in the continuity of the luminal staining. Sprouting activity corresponds to the number of filopodia bursts, clusters of filopodia emanating from the leading edge, per field of view in 4--6 20x objective images of the sprouting front for each retina. Proliferation of endothelial cells was measure by quantifying the total number of endothelial cell nuclei (labeled by Erg immunostaining) positive for EdU staining in 3--5 20x objective images, in regions containing the sprouting front, and dividing by the total area of vascularized tissue. Quantification of apoptosis in regression profiles was measured as the number of regression profiles positive for cleaved caspase-3 and divided by the total number of regression profiles in regions used for quantification, and given as percentage.

All statistical analysis was performed using Prism 5.0 (GraphPad), Oriana 4 (Kovach Computing Services) and Matlab (Mathworks) software.
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In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.

Thank you for submitting your work entitled \"Non-canonical Wnt signalling modulates the endothelial shear stress flow sensor in vascular remodelling\" for peer review at *eLife*. Your submission has been favorably evaluated by Janet Rossant (Senior editor), and three reviewers, one of whom, Ewa Paluch, is a member of our Board of Reviewing Editors.

The reviewers have discussed the reviews with one another and the Reviewing editor has drafted this decision to help you prepare a revised submission.

Summary:

This manuscript describes the role of non-canonical Wnt signalling in developing vascular beds using the retinal as a model system. The authors propose and test the hypothesis that non-canonical Wnt signaling reduces EC sensitivity to shear stress and thereby modulates vessel regression in forming vascular networks, stabilizing vessels under low flow conditions.

Essential revisions:

The reviewers find the paper interesting and solid, however several important points need to be addressed.

1\) While the interpretation of the data proposed by the authors could makes sense, the authors should explore alternative explanations of their observations by examining a possible effect of perivascular cells. Indeed, it could be that reduction of non-canonical Wnt signaling alters support from adjacent perivascular cells, which affects the response of endothelial cells to reduced flow. Along the same lines, angiotensin II might affect pericyte migration and it is not clear that its effect can be attributed exclusively to changes in blood flow (have the authors actually measured blood flows upon addition of angiotensin?)

2\) Specificity of the cre lines used: the authors should provide evidence to support the fact the knockouts are confined to ECs

3\) Could the authors better link the two systems they use and somehow connect the observations in vivo and in the HUVEC cells? Do the changes in transcription in HUVECs actually match to any degree what is seen in vivo? Alternatively, could more physiological conditions be applied to the HUVEC assay? 20 dyn/cm2 is much higher than what is typically observed in vivo, would the changes in gene expression observed also occur for lower shear stresses? Could the authors also provide some images of the HUVEC system so the reader gets a better idea of what is meant by polarity in [Figure 7](#fig7){ref-type="fig"}?

4\) In [Figure 9](#fig9){ref-type="fig"} the authors report that overexpressing Wnt5a does not prevent vessel regression. How about in the presence of angiotensin? Would overexpression of Wnt5a rescue the effect of increased blood flow?

10.7554/eLife.07727.021

Author response

*1) While the interpretation of the data proposed by the authors could makes sense, the authors should explore alternative explanations of their observations by examining a possible effect of perivascular cells. Indeed, it could be that reduction of non-canonical Wnt signaling alters support from adjacent perivascular cells, which affects the response of endothelial cells to reduced flow.*

Although the comments on pericyte may appear relevant given the long standing idea that pericyte drop out precedes vessel regression in diabetic retinopathy, recent careful studies, including ours (Franco et al. PLoS Biol 2015) illustrate that pericytes generally cover regressing vessels, and even are left behind when the endothelial cells have retracted. Nevertheless, we have now quantified pericyte coverage of retinal blood vessels from Evi WT and Evi iEC-KO. We observed no difference in terms of presence or distribution of pericytes in the KO mouse line. Additionally, it is important to note that the increased shear sensitivity of the endothelial cells in the absence of Wnt is present in the in vitro assay, which lacks pericytes (new [Figure 2](#fig2){ref-type="fig"}). We are therefore confident the observed effects are endothelial cell-autonomous.

*Along the same lines, angiotensin II might affect pericyte migration and it is not clear that its effect can be attributed exclusively to changes in blood flow (have the authors actually measured blood flows upon addition of angiotensin?)*

In accordance to the previous reply, we did not observe any significant difference in pericyte distribution or numbers in Evi iEC-KO retinas. Pericyte migration is a very difficult aspect to analyze directly with currently available methods. The fact that pericytes are present all the way to the sprouting front in the mutant retinas, like in controls, strongly indicates however that there are no major pericyte migration defects. Animal models for direct dynamic visualization of pericytes in vivo are now becoming available, but retinal live imaging in development is not yet possible, and we lack the models to do this.

We tried to measure the effects of angiotensin II on blood flow parameters using the cranial window chamber assay. However, our current methodology did not allow us to obtain consistent and satisfactory measurements. We are currently investing into development of photoacoustic imaging to overcome this limitation, but until we get there, we will likely need another year. Thus, we cannot present quantitative information on this topic. Nevertheless, there are several papers presenting strong evidence that angiotensin II increases blood pressure (Timmermans et al. Pharmacol. Rev 1993; Gembardt et al. Faseb 2008).

*2) Specificity of the cre lines used: the authors should provide evidence to support the fact the knockouts are confined to ECs*

The specificity of the cre line used has been demonstrated many times in several previous reports, including the original paper describing this line (Claxton et al. Genesis 2008) and our previous report (Franco et al. Development 2013). Figure S1 from our previous report highlights the specificity of the Pdgfb-iCre line (<http://dev.biologists.org/highwire/filestream/1203983/field_highwire_adjunct_files/0/DEV091074.pdf>). Pericytes never show recombination with the Pdgfb-iCre line.

*3) Could the authors better link the two systems they use and somehow connect the observations* in vivo *and in the HUVEC cells? Do the changes in transcription in HUVECs actually match to any degree what is seen in vivo?*

Endothelial cells in vivo are rarely in static conditions. Therefore, we can only measure gene transcription levels of endothelial cells exposed to a mixture of shear stress levels. In these conditions, we observed no significant differences of gene expression of flow-regulated genes PTGS2, KLF2, and KLF4 in EVI iEC-KO compared to EVI WT mouse retinas (new [Figure 5b](#fig5){ref-type="fig"}).

*Alternatively, could more physiological conditions be applied to the HUVEC assay? 20 dyn/cm2 is much higher than what is typically observed in vivo, would the changes in gene expression observed also occur for lower shear stresses?*

20dynes/cm2 are not uncommon values for WSS in vivo (Chatzizisis et al. J Am Coll Cardiol 2007; Gimbrone et al. Ann N Y Acad Sci 2000; Malek et al. JAMA 1999), and they are within the range of shear stress levels commonly used in the literature. Several microarray datasets (GSE8852; GSE13712; GSE16706; GSE29376) previously published showed that levels of expression of KFL2, KLF4 and PTGS2 are significantly increased upon low or high shear stress conditions.

*Could the authors also provide some images of the HUVEC system so the reader gets a better idea of what is meant by polarity in [Figure 7](#fig7){ref-type="fig"}?*

We have now included in new [Figure 8](#fig8){ref-type="fig"} images of HUVECs for the various conditions.

*4) In [Figure 9](#fig9){ref-type="fig"} the authors report that overexpressing Wnt5a does not prevent vessel regression. How about in the presence of angiotensin? Would overexpression of Wnt5a rescue the effect of increased blood flow?*

We have now quantified vessel regression in Wnt5a GOF following Angiotensin treatment. We included the quantification in the new [Figure 10](#fig10){ref-type="fig"}. We observed no significant differences in terms of vessel regression compared to control conditions. Thus, overexpression of Wnt5a does not prevent flow-dependent vessel regression.
